MBX Biosciences, Inc. Common Stock (NASDAQ: MBX) last traded at $66.33, down 0.03% on the session. The quote above updates while this page is open; the figures below are drawn from MBX Biosciences, Inc. Common Stock’s own filings and are restated only when a new one is published.
MBX Biosciences, Inc. Common Stock trades on NASDAQ under the ticker MBX. Its market capitalisation is $3.19 billion.
Valuation measures for MBX Biosciences, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $3.19B |
|---|---|
| Enterprise value | $3.17B |
| Price / book | 7.80 |
| Beta | 1.35 |
Trailing-twelve-month figures tagged in MBX Biosciences, Inc. Common Stock's XBRL filings with the SEC.
| Net income (TTM) | -$104.32M |
|---|---|
| EPS (TTM) | -$2.37 |
| Return on equity | -25.47% |
| Cash | $54.12M |
Range and volume for MBX over the past 52 weeks.
| 52-week high | $72.64 |
|---|---|
| 52-week low | $9.63 |
| Volume | 404.8K |
| Average volume | 765.4K |
| Previous close | $66.35 |
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.